| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |